It's getting mighty crowded in biotech's hippest neighborhood

Biotech's extended hot streak has put loads of money in the pockets of drugmakers, and nowhere is that clearer than in Cambridge, MA, where the boom has created demand for lab space that is outpacing supply. As CNBC reports, Cambridge's Kendall Square neighborhood, home to some industry titans, is facing historically low vacancy rates despite rising rents. More

Suggested Articles

The biotech behind AstraZeneca and the University of Oxford’s late-stage pandemic vaccine has hired Margaret (Meg) Marshall, M.D., as its new CMO.

On the heels of a merger and $60 million private offering, Compass is looking to go public. It filed to raise up to $50 million in its Nasdaq IPO.

he results suggest V114 provides broader protection from pneumococcal bacteria than Prevnar 13 does, positioning Merck to muscle in on Pfizer’s turf.